Immunological approaches of leukaemia treatment.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000818:Animals; D000961:Antilymphocyte Serum / Q000008:administration & dosage; D016026:Bone Marrow Transplantation; D002648:Child; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000008:administration & dosage; D003601:Cytotoxicity Tests, Immunologic; D006801:Humans; D007110:Immunity, Active; D007114:Immunization; D007938:Leukemia / Q000628:therapy*; D007939:Leukemia L1210 / Q000628:therapy; D007942:Leukemia, Experimental / Q000188:drug therapy; D007945:Leukemia, Lymphoid / Q000188:drug therapy / Q000628:therapy; D015470:Leukemia, Myeloid, Acute / Q000628:therapy; D015122:Mercaptopurine / Q000008:administration & dosage; D051379:Mice; D008875:Middle Aged; D009163:Mycobacterium bovis; D011070:Poly I-C
D000961:Antilymphocyte Serum; D003520:Cyclophosphamide; D015122:Mercaptopurine; D011070:Poly I-C